1.	Phase I Study of LMB-9 Immunotoxin in Patients With Advanced Solid Tumors That Express Lewis Y Antigen (Summary Last Modified 07/2002) Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-98-C-0078A, NCI-MB-400, NCI-T98-0005, T98-0005, NCT00019435
2.	Phase I Study of LMB-9 Immunotoxin in Patients With Advanced Colon, Breast, Non-Small Cell Lung, Bladder, Pancreas, or Ovarian Cancer Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSGCC-9981, MSGCC-IRB-0200123, NCI-511, NCT00005858, 511
3.	Phase I Study of LMB-9 Immunotoxin in Patients With Advanced Adenocarcinoma of the Colon, Rectum, Pancreas, Esophagus, or Stomach With Overexpression of the Lewis-Y Antigen Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UFMC-431, UFMC-IND-7697, UFMC-NSC-691236, NCI-431, EU-20120, NCT00010270, 431